Brief: Hydration Pharmaceuticals Says Net Sales In Q4 Rose 45%
31/01/2023 01:29
Jan 31 (Reuters) - Hydration Pharmaceuticals Co Ltd
HPC.AX :
* US$2.52M IN NET SALES GENERATED IN Q4 FY2022, 45% INCREASE
* FY2022 REVENUE US$9.09M, UP 49%
Source text for Eikon: ID:nASX1yKNGV
Further company coverage: HPC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman